217 related articles for article (PubMed ID: 22316280)
1. Allometric or lean body mass scaling of propofol pharmacokinetics: towards simplifying parameter sets for target-controlled infusions.
Coetzee JF
Clin Pharmacokinet; 2012 Mar; 51(3):137-45. PubMed ID: 22316280
[TBL] [Abstract][Full Text] [Related]
2. Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis.
Cortínez LI; De la Fuente N; Eleveld DJ; Oliveros A; Crovari F; Sepulveda P; Ibacache M; Solari S
Anesth Analg; 2014 Aug; 119(2):302-310. PubMed ID: 24977639
[TBL] [Abstract][Full Text] [Related]
3. Effect-Site Target-Controlled Infusion in the Obese: Model Derivation and Performance Assessment.
Cortínez LI; Sepúlveda P; Rolle A; Cottin P; Guerrini A; Anderson BJ
Anesth Analg; 2018 Oct; 127(4):865-872. PubMed ID: 29401079
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic models for propofol--defining and illuminating the devil in the detail.
Absalom AR; Mani V; De Smet T; Struys MM
Br J Anaesth; 2009 Jul; 103(1):26-37. PubMed ID: 19520702
[TBL] [Abstract][Full Text] [Related]
5. The performance of compartmental and physiologically based recirculatory pharmacokinetic models for propofol: a comparison using bolus, continuous, and target-controlled infusion data.
Masui K; Upton RN; Doufas AG; Coetzee JF; Kazama T; Mortier EP; Struys MM
Anesth Analg; 2010 Aug; 111(2):368-79. PubMed ID: 19861357
[TBL] [Abstract][Full Text] [Related]
6. Simulation analysis of the performance of target-controlled infusion of propofol in Chinese patients.
Ko YP; Hsu YW; Hsu K; Tsai HJ; Huang CJ; Chen CC
Acta Anaesthesiol Taiwan; 2007 Sep; 45(3):141-7. PubMed ID: 17972616
[TBL] [Abstract][Full Text] [Related]
7. Characterization of cardiovascular depression effect for propofol during anesthesia induction period on morbidly obese patients.
Wu Z; Li J; Wang C; Yang J; Chen X; Yang W; Xiong Z; Peng X
Biomed Pharmacother; 2018 Oct; 106():618-623. PubMed ID: 29990851
[TBL] [Abstract][Full Text] [Related]
8. Prospective clinical validation of the Eleveld propofol pharmacokinetic-pharmacodynamic model in general anaesthesia.
Vellinga R; Hannivoort LN; Introna M; Touw DJ; Absalom AR; Eleveld DJ; Struys MMRF
Br J Anaesth; 2021 Feb; 126(2):386-394. PubMed ID: 33317804
[TBL] [Abstract][Full Text] [Related]
9. Propofol clearance in morbidly obese children and adolescents: influence of age and body size.
Diepstraten J; Chidambaran V; Sadhasivam S; Esslinger HR; Cox SL; Inge TH; Knibbe CA; Vinks AA
Clin Pharmacokinet; 2012 Aug; 51(8):543-51. PubMed ID: 22690673
[TBL] [Abstract][Full Text] [Related]
10. Performance of TCI Propofol Using the Schnider Model for Cardiac Surgery on Cardiopulmonary Bypass-A Pilot Study.
Lee AKY; Kong AYH; Kong CF
J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):723-730. PubMed ID: 29225156
[TBL] [Abstract][Full Text] [Related]
11. Performance of computer-controlled infusion of propofol: an evaluation of five pharmacokinetic parameter sets.
Vuyk J; Engbers FH; Burm AG; Vletter AA; Bovill JG
Anesth Analg; 1995 Dec; 81(6):1275-82. PubMed ID: 7486116
[TBL] [Abstract][Full Text] [Related]
12. Which model for propofol TCI in children.
Constant I; Rigouzzo A
Paediatr Anaesth; 2010 Mar; 20(3):233-9. PubMed ID: 20470319
[TBL] [Abstract][Full Text] [Related]
13. The effective effect-site propofol concentration for induction and intubation with two pharmacokinetic models in morbidly obese patients using total body weight.
Echevarría GC; Elgueta MF; Donoso MT; Bugedo DA; Cortínez LI; Muñoz HR
Anesth Analg; 2012 Oct; 115(4):823-9. PubMed ID: 22956531
[TBL] [Abstract][Full Text] [Related]
14. [Accuracy of target-controlled infusion (TCI) with 2 different propofol formulations].
Ihmsen H; Jeleazcov C; Schüttler J; Schwilden H; Bremer F
Anaesthesist; 2004 Oct; 53(10):937-43. PubMed ID: 15372176
[TBL] [Abstract][Full Text] [Related]
15. Allometric relationships between the pharmacokinetics of propofol in rats, children and adults.
Knibbe CA; Zuideveld KP; Aarts LP; Kuks PF; Danhof M
Br J Clin Pharmacol; 2005 Jun; 59(6):705-11. PubMed ID: 15948935
[TBL] [Abstract][Full Text] [Related]
16. Encouraging the move towards predictive population models for the obese using propofol as a motivating example.
McLeay SC; Morrish GA; Kirkpatrick CM; Green B
Pharm Res; 2009 Jul; 26(7):1626-34. PubMed ID: 19337821
[TBL] [Abstract][Full Text] [Related]
17. Predictive performance of computer-controlled infusion of remifentanil during propofol/remifentanil anaesthesia.
Mertens MJ; Engbers FH; Burm AG; Vuyk J
Br J Anaesth; 2003 Feb; 90(2):132-41. PubMed ID: 12538367
[TBL] [Abstract][Full Text] [Related]
18. The performance of a target-controlled infusion of propofol in combination with remifentanil: a clinical investigation with two propofol formulations.
Wietasch JK; Scholz M; Zinserling J; Kiefer N; Frenkel C; Knüfermann P; Brauer U; Hoeft A
Anesth Analg; 2006 Feb; 102(2):430-7. PubMed ID: 16428538
[TBL] [Abstract][Full Text] [Related]
19. No adjustment vs. adjustment formula as input weight for propofol target-controlled infusion in morbidly obese patients.
La Colla L; Albertin A; La Colla G; Ceriani V; Lodi T; Porta A; Aldegheri G; Mangano A; Khairallah I; Fermo I
Eur J Anaesthesiol; 2009 May; 26(5):362-9. PubMed ID: 19307972
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic model for propofol for broad application in anaesthesia and sedation.
Eleveld DJ; Colin P; Absalom AR; Struys MMRF
Br J Anaesth; 2018 May; 120(5):942-959. PubMed ID: 29661412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
